Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation

BACKGROUND: Perturbing Hsp90 chaperone function targets hypoxia inducible factor (HIF) function in a von Hippel-Lindau (VHL) independent manner, and represents an approach to combat the contribution of HIF to cell renal carcinoma (CCRCC) progression. However, clinical trials with the prototypic Hsp9...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohonowych, Jessica ES, Peng, Shuping, Gopal, Udhayakumar, Hance, Michael W, Wing, Shane B, Argraves, Kelley M, Lundgren, Karen, Isaacs, Jennifer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259130/
https://www.ncbi.nlm.nih.gov/pubmed/22172030
http://dx.doi.org/10.1186/1471-2407-11-520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259130/
https://www.ncbi.nlm.nih.gov/pubmed/22172030
http://dx.doi.org/10.1186/1471-2407-11-520

Ejemplares similares